Conditions: Colorectal Adenocarcinoma; Gastric Adenocarcinoma; Pancreatic Adenocarcinoma; Bile Duct Carcinoma; Hepatocellular Carcinoma; Esophageal Carcinoma; Gastrointestinal Cancer
Intervention: Drug: CGX1321
Sponsors: Curegenix Inc.; Guangzhou Curegenix Co. Ltd.
Recruiting
https://ift.tt/2HrnU6e
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου